Ayala Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 2003
Cash & Equivalents	25.21	41.61	25.18	16.73	44.14	23.9	112.75	66.56	17.61	20.55	Upgrade
Short-Term Investments	0	0	0	0	0	46.4	39.34	45.59	0	0	Upgrade
Cash & Cash Equivalents	25.21	41.61	25.18	16.73	44.14	70.3	152.09	112.16	17.61	20.55	Upgrade
Cash Growth	-39.42%	65.28%	50.54%	-62.11%	-37.21%	-53.78%	35.60%	537.00%	-14.33%	8858547.41%	Upgrade
Receivables	0	0.68	0.47	0.47	0	4.45	2.63	1.75	1.73	0	Upgrade
Inventory	0	-0.68	1.34	0.08	0	0	5.1	1.09	1.15	0	Upgrade
Other Current Assets	0.55	1.64	0.87	0.42	6.32	6.49	0.05	0.02	0.01	0.26	Upgrade
Total Current Assets	25.76	43.26	27.85	17.69	50.47	81.24	159.88	115.01	20.49	20.81	Upgrade
Property, Plant & Equipment	0.05	0.16	7.23	1.42	6.68	7.11	4.39	1.09	0.08	0.08	Upgrade
Intangible Assets	0.11	3.35	3.26	0	4.84	4.86	4.33	3.36	2.77	2.53	Upgrade
Other Long-Term Assets	0.01	0.01	0.18	0.94	0.28	0.43	0.45	0.15	0.04	0.17	Upgrade
Total Long-Term Assets	0.17	3.52	10.68	2.36	11.8	12.4	9.17	4.59	2.88	2.78	Upgrade
Total Assets	25.93	46.78	38.53	20.05	62.27	93.64	169.04	119.61	23.38	23.59	Upgrade
Accounts Payable	0.02	2.26	1.08	2.92	9.31	7.93	3.82	1.7	1.53	3.84	Upgrade
Deferred Revenue	0	0.67	0.17	0	4.48	7	15.02	0	0	0	Upgrade
Current Debt	0.01	0.03	0.96	0	2.53	5.89	8.81	0.03	0.06	0.23	Upgrade
Other Current Liabilities	2.27	4.93	1.08	2.38	6.57	0.05	0.06	2.19	1.12	0.87	Upgrade
Total Current Liabilities	2.3	7.88	3.29	5.3	22.87	20.86	27.71	3.92	2.72	4.94	Upgrade
Long-Term Debt	0	0.01	5.06	0.3	0	0	325.16	0	0	0	Upgrade
Other Long-Term Liabilities	0	0	0	0	15.34	18.52	-303.12	0.09	0.03	0.65	Upgrade
Total Long-Term Liabilities	0	0.01	5.06	0.3	15.34	18.52	22.04	0.09	0.03	0.65	Upgrade
Total Liabilities	2.3	7.89	8.35	5.6	38.22	39.38	49.74	4.01	2.75	5.58	Upgrade
Total Debt	0.01	0.04	6.02	0.3	0	0	325.16	0.03	0.06	0.23	Upgrade
Debt Growth	-70.00%	-99.34%	1912.37%	-	-	-	1100309.49%	-53.01%	-72.18%	-52.64%	Upgrade
Common Stock	0	0.15	0.08	0.09	0.07	0.04	0.04	0.03	0.02	0.01	Upgrade
Retained Earnings	-442.96	-428.6	-410.74	-40.74	-367.66	-301.14	-207.71	-134.05	-86.99	-70.47	Upgrade
Comprehensive Income	0	0	0	0	0	-1.21	-0.43	-0.14	-0.26	-0.23	Upgrade
Shareholders' Equity	23.63	38.89	30.18	14.45	24.05	54.26	119.3	115.6	20.63	18	Upgrade
Total Liabilities and Equity	25.93	46.78	38.53	20.05	62.27	93.64	169.04	119.61	23.38	23.59	Upgrade
Net Cash / Debt	25.2	41.57	19.16	16.43	44.14	70.3	-173.07	112.13	17.54	20.33	Upgrade
Net Cash / Debt Growth	-39.39%	116.97%	16.65%	-62.79%	-37.21%	-	-	539.12%	-13.69%	-	Upgrade
Net Cash Per Share	13.85	25.76	25.13	86.41	1028.09	2081.49	-5866.86	4800.97	1230.72	4867.35	Upgrade
Working Capital	23.46	35.38	24.56	12.39	27.59	60.38	132.17	111.1	17.78	15.87	Upgrade
Book Value Per Share	12.99	24.10	39.58	76.03	560.17	1606.61	4044.14	4949.64	1447.21	4310.86	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.